Characterization of selectivity and pharmacophores of type 1 sea anemone toxins by screening seven Nav sodium channel isoforms  by Zaharenko, André Junqueira et al.
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During  their  evolution,  animals  have developed  a set of  cysteine-rich  peptides  capable  of binding  vari-
ous  extracellular  sites  of  voltage-gated  sodium  channels  (VGSC).  Sea  anemone  toxins  that target  VGSCs
delay  their  inactivation  process,  but  little  is  known  about  their  selectivities.  Here  we  report  the investiga-
tion  of  three  native  type  1  toxins  (CGTX-II,  -AITX-Bcg1a  and  -AITX-Bcg1b)  puriﬁed  from  the  venom  of
Bunodosoma  cangicum.  Both  -AITX-Bcg1a  and  -AITX-Bcg1b  toxins  were  fully  sequenced.  The  three  pep-
tides  were  evaluated  by  patch-clamp  technique  among  Nav1.1–1.7  isoforms  expressed  in  mammalian
cell  lines,  and  their  preferential  targets  are Nav1.5 > 1.6 > 1.1.  We  also evaluated  the  role of  some  sup-
posedly  critical  residues  in  the  toxins  which  would  interact  with  the  channels,  and observed  that  someodium channels
nactivation process
atch-clamp
oxins selectivity
substitutions  are  not  critical  as  expected.  In  addition,  CGTX-II  and  -AITX-Bcg1a  evoke  different  shifts  in
activation/inactivation  Boltzmann  curves  in  Nav1.1  and  1.6.  Moreover,  our results  suggest  that  the  inter-
action  region  between  toxins  and  VGSCs  is  not restricted  to the  supposed  site 3  (S3-S4  linker  of  domain
IV),  and  this  may  be a consequence  of  distinct  surface  of contact  of each  peptide  vs.  targeted  channel.  Our
data  suggest  that  the  contact  surfaces  of  each  peptide  may  be  related  to their  surface  charges,  as  CGTX-II
is more  positive  than  -AITX-Bcg1a  and  -AITX-Bcg1b.. Introduction
Voltage-gated sodium channels (VGSCs) represent the excitabil-
ty face of the nervous, muscular and cardiac systems because
hey participate in the generation and propagation of action poten-
ials. They are composed of a pore-forming -subunit associated
ith up to four known different -subunits. The tetrodotoxin
TTX)-sensitive Na+ channels are classiﬁed according to sequence
omology as Nav1.1 to Nav1.7 and they are differentially dis-
ributed in the central and peripheral nervous system, in skeletal
uscle, and in cardiac muscle. VGSC and K+ channels dysfunc-
ion (channelopathies) can result in neuromuscular diseases and
eart or brain disorders such as arrhythmias and epilepsy [1,14,18].
Abbreviations: CGTX-II, cangitoxin-II; VGSC, voltage-gated sodium channels.
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Mutations in the genes encoding for Nav1.1 and Nav1.2 isoforms
have been linked to various forms of epilepsy and febrile seizures
[21]. Thus, the key role of VGSCs in many tissues makes them impor-
tant targets for pharmacological and biophysical studies, especially
by dissecting the speciﬁc toxin–channel interactions.
The investigation on the pharmacology of sodium channel tox-
ins from sea anemones started more than 30 years ago [4,26],  and
further studies on site-directed mutagenesis took place later in the
1990s [11,15,16,25].  Nevertheless, very few information on electro-
physiological and selectivity effects in a broader range of channels
was reported [6,23].
Sea anemone type 1 toxins are peptides whose binding sites
in VGSCs partially overlap with those of -scorpion toxins. Their
actions involve almost completely and selectively to induce a
particular delay in ion channel conformational change called inac-
tivation (transition from the open to the shut state) as opposed
to the early process of activation (opening of the Na+-selective
pore). This inactivated state is distinct from the closed state and
Open access under the Elsevier OA license.there are many different methods to manipulate it from the intra-
cellular side, either by using enzymes [2],  drugs, point mutations
(for a review see Ulbricht [33]) and speciﬁc toxins from venomous
animals.
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In the present paper, we studied three sea anemone type 1 tox-
ns (CGTX-II, -AITX-Bcg1a and -AITX-Bcg1b) puriﬁed from the
enom of the sea anemone Bunodosoma cangicum. Two of those tox-
ns (-AITX-Bcg1a and -AITX-Bcg1b) differ in only one amino acid
N16D), but their potencies are markedly different. Also, in contrast
o CGTX-II, both -AITX-Bcg1a and -AITX-Bcg1b have substitu-
ions at positions 36–38. These positions were reported, in other
ea anemone toxins, to be involved in the toxin–channel interac-
ion, then inducing a robust increase in the slow component of the
nactivation [5,25,28,31], which is the origin of the physiological
rolongation of the action potential.
In this work we also aimed to investigate all the biophysical
roperties crucially involved in the action produced by these tox-
ns on the inactivation process of the sodium current, especially
aking into account that the selectivity of these types of peptides
mong the subtypes of VGSCs is poorly known. Also, we evaluated
y molecular modeling the charge distribution among the three dif-
erent toxins, which may  be implied in their different potencies and
electivities. We  should also mention that in order to standardize
he as yet confusing nomenclature of animal toxins, -AITX-Bcg1a
nd -AITX-Bcg1b were named following a nomenclature rationale
ecently proposed [17].
. Materials and methods
.1. Toxins puriﬁcation
.1.1. Venom collection, fractionation and puriﬁcation of toxins
Forty B. cangicum specimens were collected on the northern
oast of São Paulo State, Brazil, and the venom was  obtained
y electrical stimulation of animals as previously described [20].
he B. cangicum venom (approximately 150 mg)  was  fraction-
ted by gel ﬁltration chromatography using a Sephadex G-50
olumn (1.9 cm × 131 cm,  GE Healthcare, Uppsala, Sweden), as
escribed [19,23].  Pools of the neurotoxic fraction, eluted in the
hird peak (Fr III), were submitted to RP-HPLC chromatography
n an ÄKTA Puriﬁer machine (GE Healthcare, Uppsala, Sweden)
sing a semipreparative CAPCELL PAK C-18, 10 mm × 250 mm (Shi-
eido Corp., Kyoto, Japan) column. Approximately 10 mg  of the
eurotoxic pool were fractionated (1 mg  per run) by RP-HPLC.
he HPLC conditions used were: 0.1% triﬂuoroacetic acid (TFA) in
ater (solvent A) and acetonitrile containing 0.1% TFA (solvent
). The separations were performed at a ﬂow rate of 2.5 mL/min
nd a 10–60% gradient of solvent B over 40 min. The eluted pep-
ides were monitored at UV 214 nm,  as described [36]. The peaks
luted at 30.24 and 30.57 min, respectively, were manually col-
ected and lyophilized or concentrated for further re-puriﬁcations
36]. Each of these components were re-puriﬁed twice by employ-
ng isocratic condition at 29% of solvent B, in order to best ﬁt the
uriﬁed peptides to proper peak symmetry. After obtaining good
eak symmetries suggesting high purity, molecular mass assess-
ents by MALDI-Tof mass spectrometry were carried out. The
eptide cangitoxin-II (CGTX-II) was puriﬁed as previously reported
35]. The protein contents of both the neurotoxic fraction and the
ure peptide samples were estimated by the bicinchoninic acid
BCA) method (Pierce, Rockford, USA) following the manufacturer’s
nstructions.
.1.2. Mass spectrometry analyses
Analyses of pure peptides obtained in the previous step were
erformed on an Ettan MALDI-TOF/Pro (GE Healthcare, Upp-
ala, Sweden) equipped with 337 nm pulsed nitrogen laser under
eﬂectron mode. The accelerating voltage was  20 kV. Matrix,
-cyano-4-hydroxycinnamic acid (Sigma–Aldrich Co., USA), was
repared at a concentration of 10 mg/mL  in 1:1 CH3CN/0.1% TFA.s 34 (2012) 158–167 159
External calibration was  performed with [Ile7]-angiotensin III (m/z
897.51, monoisotopic, Sigma) and insulin (m/z  5734.49, average,
Sigma). The sample solution (0.5 L) dropped onto the MALDI sam-
ple plate was  added to the matrix solution (0.5 L) and allowed to
dry at room temperature.
2.1.3. Determination of amino acid sequences
The N-terminal amino acid sequences of the native peptides
were determined by automated Edman degradation using a Shi-
madzu PPSQ-21A protein sequencer. To obtain their complete
sequences, the peptides were reduced and S-alkylated with vinyl
pyridine according to the method described by Henschen [13].
Each sample was  dissolved in 1 mL  of 6 M guanidine–HCl in 0.1 M
tris–HCl, pH 8.6. To this solution 30 L of 2-mercaptoethanol was
added under nitrogen and the sample incubated at 50 ◦C for 4 h.
After this, 40 L of 4-vinylpyridine was added and the samples were
incubated under nitrogen at 37 ◦C in the dark during 2 h. The sam-
ples were then desalted on a Vydac C4 column, using a gradient
of 0–65% acetonitrile in 0.1% TFA during 140 min and lyophilized.
The S-pyridyl-ethylated peptides were dissolved in 200 L of 8 M
urea, and then diluted with 1.8 mL  of 0.1 M ammonium bicarbon-
ate (pH 7.9) and digested at 37 ◦C with chymotrypsin (2%, w/w
enzyme/substrate) for 3 h. The peptides produced by this digestion
were separated by reverse phase HPLC on a Vydac C-18 column
(4.6 mm × 250 mm,  i.d.) (small pore) using an extended gradient of
0–50% acetonitrile in 0.1% triﬂuoroacetic acid for 180 min  at a ﬂow
rate of 1 mL/min.
2.2. Electrophysiology in Nav1.x isoforms
2.2.1. Cell culture
HEK293 cell lines stably expressing human NaV1.1, 1.2, 1.3, 1.5
and 1.6 (generously donated by GlaxoSmithKline, Medicines Res.
Centre, Gunnels Wood Rd., Stevenage, Herts SG1 2NY, UK) were
cultured in modiﬁed Dulbecco’s medium supplemented with 10%
fetal bovine serum as described [23]. NaV1.4-expressing cells were
obtained by stably transfecting a plasmid containing the hNav1.4
construct (a kind gift from Prof. Diana Conti-Camerino, University
of Bari, Italy). NaV1.7-expressing cells were obtained by transient
transfection of a plasmid containing the hNaV1.7 construct (a
kind gift from Prof. Franz Hofmann through Prof. Akihiko Wada,
University of Miyazaki, Japan). Approximately 2 × 104 cells were
transfected with 2 g of hNaV1.7 vector along with 0.2 g of green
ﬂuorescent protein (GFP) in pEGFP-C1 (Clontech, USA) using lipo-
fectamine reagent kit (Invitrogen, USA) following the instructions
of the manufacturer. Currents were recorded 24–72 h following
transfection.
2.2.2. Solutions and drugs
The standard extracellular solution contained (mM):  NaCl 70,
N-Methyl-d-Glucamine 67, CaCl2 1, MgCl2 1.5, HEPES 5, d-glucose
10 at pH 7.40. The standard pipette solution contained (mM): CsF
105, CsCl 27, NaCl 5, MgCl2 2, EGTA 10, Hepes 10 at pH 7.30.
About 6–8% of the cells in the clone expressing NaV1.6 channels
had a persistent Na+ current, as reported by Burbidge et al. [7].
We  systematically tested these cells and discarded those show-
ing incomplete inactivation (a residual current after 250 ms  of
<0.1% of the peak Na+ current). Known quantities of the toxins
were dissolved in the extracellular solution immediately before the
experiments. Tetrodotoxin (TTX, Sigma, Italy) was used at 300 nM
on the NaV1.1, 1.2, 1.3, 1.4, 1.6 and NaV1.7 currents and the resulting
traces were subtracted from the control traces to obtain the TTX-
sensitive currents; the NaV1.5 clone (which has a TTX ID50 much
higher than 100 nM)  never showed any signiﬁcant contaminating
potassium currents at the test potentials. The extracellular solu-
tions were delivered through a remote-controlled 9-hole (0.6 mm)
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Fig. 1. Quantitative screening of the effects of the three toxins on the seven isoforms. The fractional ratio of the increase of the slow component in the decaying part of the
sodium current is plotted vs. high (1.9 M)  and low (50 nM)  concentrations and vs. the seven VGSC isoforms. Thin bars indicate low concentrations. Each bar is the average
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.2.3. Patch-clamp recordings and data analysis
The currents were recorded at room temperature using the
ultiClamp 700A ampliﬁer (Axon Instruments, USA) as previously
escribed [23]; pipette resistance was about 1.3–2.1 M.  The cell
apacitance and series resistance errors were carefully (85–90%)
ompensated before each run of the voltage clamp protocol in order
o reduce voltage errors to less than 5% of the protocol pulse. The
/N leak procedure was routinely used. pClamp 8.2 (Axon Instru-
ents, U.S.A.) and Origin 7 (Microcal Inc, USA) softwares were used
uring data acquisition and analysis. All data regarding activation
ere obtained using a holding potential of −90 mV,  a 100 ms  pre-
onditioning of −120 mV  (to completely remove fast inactivation)
nd a 7 ms  test pulse from −80 to +40 mV.  For steady-state inactiva-
ion (but, intentionally excluding the slow inactivation), the 200 ms
reconditioning was variable from −120 to +10 mV  and the test
ulse was to −20 or −10 mV.  To obtain the conductance-voltage
ata, the peak currents were divided by the driving force (VM +
7) and normalized using peak conductance values in the range
10/+30.
.2.4. Data analysis, ﬁtting procedures and qualitative screening
t high (1.9 M) and low concentrations (50 nM)
As a general rule, we followed the procedures previously
escribed [23,30].  This procedure was based on the assump-
ion that each Na+ current trace is the sum of two  exponential
ecaying components, which are the slow (s) and the fast (f) com-
onent (see the representative inset to Fig. 1), and eventually
 steady-state (ss) component. We  used as parameter for thesets with the ﬁtting procedure to dissect Af and As components from the toxin trace.
components, their amplitude (as calculated by the Clampﬁt pro-
gram (Axon Instruments, USA). Under control conditions, the
amplitude of the fast component (Af) was generally large and
the amplitudes of the slow (As) and steady-state (Ass) compo-
nents were very low or negligible. During toxin action, a large
increase in the As occurred depending on the isoform (and was
occasionally associated with an increase in Ass). This strongly sug-
gests that the currents recorded in the presence of toxin were
always the sum of two  types of currents: those deriving from toxin-
bound channels (modiﬁed) and those deriving from toxin-free
channels (not modiﬁed and thus equivalent to control channels)
[23,30].
Preliminary procedures used in Fig. 1. We  examined about 80 ms
of each trace in control and computed Af and its time constant
(f). In the presence of the toxin, we  retained f of control and
computed: (1) the amplitude of the fast-inactivating component
originating from the unbound channels, namely Af, and (2) the As
component, originating from the toxin-bound channels (see repre-
sentative inset to Fig. 1) [30].
Procedures used in Figs. 2–4.  This type of analysis is slightly dif-
ferent from the analysis reported in Oliveira et al. [23] because the
voltage-dependent steady-state inactivation data were obtained as
the ratio of the peak currents (Af + As + Ass) obtained at the pre-
conditioning voltages (from −110 to +10 mV)  and the maximal
value obtained at −110 mV.  From −110 to +10 mV  we observed
the normal decrease of the Af and As components, but also the
increase of the Ass component as shown in the inset to Fig. 2
upper-right (see under Nav1.1 panel). The steady-state inactiva-
tion resulted to have a sigmoidal voltage-dependent curve, which,
differently from control curves, was characterized by a non com-
plete inactivation and a pedestal at depolarized potentials. This
A.J. Zaharenko et al. / Peptides 34 (2012) 158–167 161
Fig. 2. Voltage-dependent activation/inactivation for Nav1.5, Nav1.6 and Nav1.1 isoforms and recordings from representative cells. Columns and rows correspond to indicated
isoforms and toxins, respectively. In each plot the steady-state inactivation (squares) and the activation (circles) are plotted; data with closed or open symbols correspond
to  control and toxin (CGTX-II, 5 and -AITX-Bcg1a, 1.9 M),  respectively. For each isoform and each toxin concentration not less than 5 cells were used. Lines are best-ﬁtted
Boltzmann curves whose values in control and in toxin, and statistical signiﬁcance are shown in Table 2. Insets show superimposed traces obtained in a representative cell in
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he  Ass component both during preconditioning and test potentials and explains the
ast Ass effect indirectly and strongly affected the window current
normally negligible in control), thus producing a small and not
lways signiﬁcant left-shift of the activation curves. When neces-
ary the dose-response relationships of As and Ass components were
omputed in Fig. 4.
.3. Molecular modeling and visualization
In order to visualize the 3D structure of each studied toxin,
odels of CGTX-II, -AITX-Bcg1a and -AITX-Bcg1b were con-
tructed using the SWISS-MODEL structure homology-modeling
erver (http://swissmodel.expasy.org/workspace/) [3].  The tri-
imensional structure of Anthopleurin-A toxin (determined by
MR) [24] (PDB ID: 1ahl) was employed as a template for all mod-
ls. The structures were drawn and visualized by DeepView/PDB
iewer [12] (http://www.expasy.org/spdbv, version 4.0.1) and
yMOL (The PyMOL Molecular Graphics System, Version 1.2,
chrödinger, LLC., http://www.pymol.org), and were rendered by
ovRay (version 3.6 by Persistence of Vision Raytracer, Pty., Ltd.). All
he three models were validated by the tools Anolea, DFire, QMEAN,
romos, Promotif and ProCheck, available in the “structure assess-
ent” tool of the SWISS-MODEL structure homology-modeling
erver..5 and 1.9 M).  The inset in the upper-right panel relative to isoform Nav1.1 shows,
, −35 and +10 mV with the relative tests at −20 mV.  This illustrates the increase of
stal at ∼0.2 in the inactivation curve at less negative potentials.
3.  Results
3.1. Isolation of toxins and determination of primary sequences
The toxins employed in this study were obtained according
to the previously described procedures [35,36]. Considering an
urgent need for standardization of nomenclature of animal tox-
ins, especially in sea anemones, we  employed a rationale recently
suggested [17] for the novel components eluted during RP-HPLC
at 30.24 and 30.57 min  from the neurotoxic fraction of B. cangicum
venom. These peptides were named as -Actitoxin-Bcg1a (-AITX-
Bcg1a) and -Actitoxin-Bcg1b (-AITX-Bcg1b), respectively. This
rationale follows the biological effects exerted by the toxin (
letter for toxins that delay the inactivation process of ion chan-
nels) and the family of the organism which the toxin is derived
(“Actitoxin” for toxins isolated from sea anemones of the “Actini-
idae” family). Also, full sequences of each peptide were determined
in this work. Both sequences were deposited at Uniprot server
(http://www.ebi.ac.uk/uniprot/) and their accession numbers were
assigned as P86459 and P86460, respectively. As CGTX-II (Uniprot
ID: P0C7P9) had already been published [35], we  have not changed
its name.
Initially, approximately 50 g of each native peptide was
sequenced by the automated Edman degradation technique, and
162 A.J. Zaharenko et al. / Peptides 34 (2012) 158–167
Fig. 3. Voltage-dependent activation/inactivation for Nav1.4, Nav1.2 and Nav1.3 isoforms and recordings from representative cells. Columns and rows correspond to indicated
isoforms  and toxins, respectively. In each plot the steady-state inactivation (squares) and the peak activation (circles) is plotted; data with closed or open symbols correspond to
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urves  whose control values and changes in toxins are shown in Table 2. Insets sho
oxin  concentrations (CGTX-II, 1.9 and 5 M;  -AITX-Bcg1a, 0.5 and 1.9 M).
oth peptides were directly sequenced up to the 39th residue. Con-
idering that the peptides were not entirely sequenced, a protocol
or reduction and alkylation, followed by digestion, was employed.
o achieve this, the reduced and S-alkylated peptides were digested
ith chymotrypsin and the resulting products were separated into
our (-AITX-Bcg1a) and three (-AITX-Bcg1b) peaks by RP-HPLC.
owever, there were two peptides puriﬁed from the digestion
roducts of -AITX-Bcg1a, showing the Asn and Asp amino acids
t position 16. On the other hand, during sequencing of the native
eptide, only the N16 amino acid was observed. Thus, we  assume
hat the amino acid D might have been produced either as a conver-
ion of N to D during the S-pyridyl-ethylation or during digestion
f the sample, and that it does not reﬂect the occurrence of both
esidues in the native materials employed in the electrophysiology
ssays. Also, the molecular mass determinations of -AITX-Bcg1a
resent only the signal representing the N16 compound [(M+H)+,
verage] at m/z 4781.704.
For both -AITX-Bcg1a and -AITX-Bcg1b peptides their
ull sequences were cross checked by the server Prospec-
or of the University of California in Santa Barbara, USA
http://prospector.ucsf.edu/prospector/mshome.htm). Their the-
retical molecular masses [(M+H)+, average] at m/z 4781.450
-AITX-Bcg1a) and [(M+H)+, average] at m/z  4782.430 (-AITX-
cg1b) perfectly matched the experimentally determined ones
4781.704 and 4782.235, respectively, shown in supplementary
aterial), considering the three S–S bonds formed. Additional data
n these sequence determinations is provided as “supplementary
aterial” in the supplementary Figs. 1 and 2. The primary sequence
lignment of the peptides investigated is depicted in Table 1. each toxin concentration at least 4 cells were used. Lines are best-ﬁtted Boltzmann
erimposed traces obtained in a representative cell in control and at two different
3.2. Qualitative screening at high and low concentrations
During the evaluation of the toxins we  performed experiments
both at high and saturating concentrations (see below in Fig. 4)
and, at much lower concentrations, in those cases in which it
was evident that the effects were interesting and pronounced.
The experiments (see Methods Section 2.2.4) were designed to
reduce the time-consuming electrophysiological protocols which
indirectly let us to diminish the amount of toxin used in each test.
The results of these preliminary experiments are summarized in
Fig. 1 where the ratio As/(As + Af), here called fractional amplitude
of the slow component of the current inactivation is plotted both
vs. each channel isoform and each peptide. It can be seen that at
saturating concentrations of 1.9 M,  toxin -AITX-Bcg1b was prac-
tically without effects in all the isoforms. On the contrary, the other
two peptides (-AITX-Bcg1a and CGTX-II) were found to produce
robust effects in all the isoforms except Nav1.7. These peptides were
also tested at a much lower concentration, where we were able to
observe a very selective property for only one (-AITX-Bcg1a on
Nav1.5) or two isoforms (CGTX-II on Nav1.5 and Nav1.6).
3.2.1. Toxins selectivity on Nav1.x isoforms
Since no effects were seen on the Nav1.7 isoform and the toxin
-AITX-Bcg1b had little effect in any of the seven isoforms tested,
we restricted our detailed analysis only to the ﬁrst six isoforms as
outlined below in Figs. 2–4.
In Fig. 2 (for VGSC isoforms Nav1.5, Nav1.6 and Nav1.1) and
Fig. 3 (for Nav1.4, Nav1.2 and Nav1.3) the voltage-dependent data
(symbols) are shown in six plots each, where the two rows and
A.J. Zaharenko et al. / Peptides 34 (2012) 158–167 163
Fig. 4. Vulnerability of each Nav1.x isoform against different types of sea anemone toxins. Each graph describes the dose response curves of the fractional increase of As .
Insets  to Nav1.5, Nav1.6 and Nav1.1 isoforms plots show the fractional increase of the Ass (note the different y-scales as compared panels; the x-scale is in nM). CGTX-II and
-AITX-Bcg1a toxins data are shown as Hill curves (continuous lines, n = 5 for each isoform) best ﬁtting experimental points (closed and open squares, respectively). The non-
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-AITX-Bcg1a at 1.9 M)  and channel isoforms, respectively. All
he quantitative data are shown in Table 2 where the typical
iophysical properties are reported together with the statistical
igniﬁcance of the differences observed for the action of the two
oxins.
able 1
rimary sequence alignment of some Type 1 sea anemone toxins. Below are depicted t
except cangitoxin). The peptides employed in this work have gray background names an
olors  backgrounds mean identical, different and similar amino acids, respectively.
 denotes hydroxyproline amino acid in CgNa. Note the N16D substitution in ı-AITX-Bcg
nteresting the occurrence of the negatively charged amino acid D37 in ı-AITX-Bcg1a and
mportance of these residues, refer to Section 4.sh-dot line) and BcIII (dots line) [23]. The Hill curve data for the following isoforms
ope 103 ± 8 nM,  slope 1.8 ± 0.2 (440 ± 32, slope 1.2 ± 0.1) for Nav1.5, 133 ± 12 nM,
53 ± 31, slope 1.36 ± 0.15) for Nav1.1.
As illustrated in Fig. 2 upper panels, CGTX-II affects isoform
Nav1.5 differently from isoforms Nav1.6 and Nav1.1. In Nav1.5 the
effect consists in a right-shift of inactivation; on the contrary in both
Nav1.6 and Nav1.1 the effect consists in an incomplete inactivation
from −40 up to +10 mV.  The latter effect is due to a strong non-
inactivating Ass component that increased in a voltage-dependent
oxins that have been subjected to extensive electrophysiological characterization
d are obtained from the species Bunodosoma cangicum [36]. Black, white and gray
1a to ı-AITX-Bcg1b and cangitoxin-II, as well as in BgII and BgIII peptides. Also, it is
 ı-AITX-Bcg1b, as well as the D36 and E37 in CgNa peptide. For more details on the
164 A.J. Zaharenko et al. / Peptides 34 (2012) 158–167
Table 2
Parameters from best ﬁts to Boltzmann equations in Figs. 2 and 3 and statistical signiﬁcance. Control data are derived by ﬁtting procedure as explained in Methods (see
Section  2.2.4). A two-sample paired t-test was done on the theoretical curves (15 points) best-ﬁtting the experimental curves (in control and toxins) and one * or two **
denoted the statistical signiﬁcance at levels of 0.05 or 0.001, respectively. Concentrations of CGTX-II and -AITX Bcg1a were 5 and 1.9 M,  respectively.
Toxin Property Nav1.1 Nav1.2 Nav1.3 Nav1.4 Nav1.5 Nav1.6
Control n = 66 Activation V½ −15.8 ± 0.4 −14 ± 0.2 −10 ± 0.3 −21.3 ± 0.4 −40 ± 0.5 −16.8 ± 0.6
Slope  7.5 ± 0.4 6 ± 0.2 5.6 ± 0.6 6 ± 0.3 5.7 ± 0.2 7.1 ± 0.4
Inactivation V½, mV −50.1 ± 1.5 −55 ± 1.4 −49 ± 1.2 −66.7 ± 1.9 −71.5 ± 2.1 −55.7 ± 1.2
Slope  6.2 ± 1.3 8.5 ± 1.3 8.7 ± 1.3 7.9 ± 1.3 8.2 ± 1.3 9.9 ± 1.3
CGTX-II Activation n = 33 – * * * – *
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-AITX  Bcg1a Activation n = 33 ** –
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anner. The reason that is behind this action is shown in the inset of
av1.1 isoform to Fig. 2 (upper-right panel) during the toxin action.
he three superimposed traces elicited from −80, −35 and +10 mV,
nd immediately tested at −20 mV,  show how the toxin exerts its
ffect by re-shaping the control steady-state inactivation and, at
he same time, producing a small left-shift of the activation that
esulted signiﬁcant only for some isoform (see Table 2). This type
f action is able to strongly modify the so called “window current”
hat is know to be able to alter the neuronal resting potential [9,33].
Besides isoform Nav1.5, also isoforms 1.4, 1.2 and 1.3 (shown
n Fig. 3) are much less affected by the 2 toxins and did show only
arginal and sometimes not signiﬁcant effects. We  noticed also
mall, but signiﬁcant (p < 0.05) effects of left-shifts of the voltage-
ependent activation curves. CGTX-II produced very signiﬁcant
ffects (p < 0.01) on inactivation in all isoforms except Nav1.2 and
av1.4.
On the whole, these results suggest that the two different tox-
ns were able to produce also different types of effects. Namely, it is
ossible to notice that CGTX-II was a toxin able to produce, only on
he Nav1.5 isoform, a right-shift of the inactivation curve, whereas
ll the other effects consisted in a more or less non complete inac-
ivation process.
.2.2. The dose-dependent action of the peptides and the VGSC
soforms vulnerability to different sea anemone toxins
Our present data and those previously described [23] for other
ea anemone toxins, namely ATX-II, AFT-II and BcIII, constitute a set
f results obtained with native peptides and could thus be useful to
e compared. In order to do so, we plotted the fractional slow com-
onent (As/(As + Af)) increase vs. toxin concentration for the six most
ffected isoforms, and in Fig. 4 a comprehensive dose–response
ummary is shown where also the data reported in Oliveira et al.
23] have been superimposed.
As illustrated by the legends, CGTX-II (closed squares) and -
ITX-Bcg1a (open squares) data are plotted both as data points and
est ﬁtted Hill curves (see legend for the EC50 and Hill coefﬁcients).
It appears that three isoforms, namely Nav1.5, Nav1.6 and
av1.1, show EC50s in the region 80–150 nM.  For the other isoforms
e estimated EC50 values of ∼5 M CGTX-II for Nav1.4, and values
15 M for both toxins in Nav1.2 and Nav1.3. A statistical evalua-
ion of the pairs CGTX-II and -AITX-Bcg1a suggested that the data
f the three isoforms Nav1.5, Nav1.6 and Nav1.1 were different at
evel of p < 0.05. On the other hand, the other isoforms were much
ess affected and the effects did not appear signiﬁcantly different.
To complete the picture, the fractional effects produced on the
ss component are included as insets to the appropriate plots. By
omparing these data, it is evident that the two toxins here investi-
ated produced a large Ass increase only in the isoforms Nav1.1 and
av1.6. As compared to similar Ass data, but for ATX-II, AFT-II and
cIII, present in Oliveira et al. [23], it is evident the toxins inves-
igated in the present report show potencies (in the 100–500 nM
ange), which were similar to those shown by the other peptides.** – ** **
* – – –
– – ** **
3.2.3. 3D models and molecular surfaces
As shown in Fig. 5, the three toxins investigated were mod-
eled and structurally represented, in order to get some clues about
the role of some amino acids and their surfaces charges in their
activities. The three models were validated and yielded values as
expected, based on the template. The QMEAN scores for CGTX-II,
-AITX-Bcg1a and -AITX-Bcg1b were 0.7, 0.71 and 0.74, respec-
tively. Panel A shows the cartoon representation of each peptide,
and panel B shows the molecular surfaces of the corresponding
molecules in the same orientation of panel A. Also, R14 located in
the ﬂexible loop comprised from residues D9-S19 is depicted as blue
spheres in panel A, as well as other negatively charged D residues
colored as red.
It can be clearly seen in panel B that the overall charged molec-
ular surface of CGTX-II is different than those -AITX-Bcg1a and
-AITX-Bcg1b peptides. In that orientation, CGTX-II is more positive
than -AITX-Bcg1a, which in turn is less negative than -AITX-
Bcg1b. For -AITX-Bcg1a and -AITX-Bcg1b, the occurrence of D37
possibly contributes to the formation of a continuum of a negative
patch that extends along the surface of the molecules. Especially
in case of -AITX-Bcg1b which also presents the D16 amino acid
(its single substitution compared to -AITX-Bcg1a), showing in this
case its role in the formation of the dense overall negative charge
of -AITX-Bcg1b. Considering the occurrence of an Asn in the 16th
position in -AITX-Bcg1a, this negative patch is not as intense as
in the case of -AITX-Bcg1b. Thus, due to this difference we  may
speculate that its potency may  be expected to be similar to that of
CGTX-II.
4. Discussion
Initially we  should emphasize that both -AITX-Bcg1a and -
AITX-Bcg1b toxins had their primary sequences fully determined in
this work, then making possible to explore their molecular aspects
more in detail. As observed in Fig. 1, the selectivity of the CGTX-II, -
AITX-Bcg1a and -AITX-Bcg1b toxins is highest for Nav1.5 followed
by 1.6 and 1.1 (Nav1.5 > 1.6 > 1.1). -AITX-Bcg1b was not shown to
be potent and was  consequently abandoned in our investigation. It
is important to remind that -AITX-Bcg1b presents the single N16D
substitution in relation to its isoform -AITX-Bcg1a (see Table 1).
The latter shows a much higher potency among the assayed chan-
nels. However, CGTX-II also presents a D16 amino acid (see Table 1),
but its potency and selectivity are close to the observed for -AITX-
Bcg1a. In that case, it is clear that the N16 amino acid alone should
not be considered as a key determinant of the potency or activity
of sea anemone peptides.
In the work by Oliveira et al. [23], the selectivity of ATX-II (see its
primary sequence in Table 1) was  Nav1.1–1.2 > 1.5 > 1.4 > 1.6 > 1.3,
while its isoform AFT-II (with an extra Gly at N-terminus and
a single K36A substitution, in relation to ATX-II) was  selective
as Nav1.4 > 1.5 > 1.6 > 1.3–1.1 > 1.2. The toxin BcIII (more alike to
CGTX-II) was assayed in that work, showing a preferential activity
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Fig. 5. Tri-dimensional molecular models of CGTX-II, -AITX-Bcg1a and -AITX-Bcg1b. Panel A shows the cartoon representation of each peptide, with the spheres represen-
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n Nav1.5–1.1 > 1.4–1.6 > 1.2–1.3. More recently, these three pep-
ides were assayed in Nav1.7 and all of them showed a smaller
otency in that channel [34], such as for CGTX-II, -AITX-Bcg1a
nd -AITX-Bcg1b here presented. The compilation of those data,
ogether with a summary of the dose–response curves in the
resent study, is shown in Fig. 4. Contrary to AFT-II and BcIII,
one of the toxins employed in this study showed some preference
or binding to Nav1.4. Thus, it is clear that the selectivity of sea
nemone type 1 toxins is variable, and consequently the surface of
ontact of each peptide should vary as well.
Other authors tried to investigate this aspect [22]. They did a
ull alanine scanning of ATX-II (Av2) toxin, and found that some
esidues important for activity coincide, but many do not overlap
ith the contact surface of the structurally related peptide ApB
5,10,31]. On the other hand, although differing only by N16D sub-
titution, previous studies demonstrated that BgII (Asn) is much
ore potent than BgIII (Asp) (see Table 1) [6,28].  Consequently,
his conﬁrms that the role of each individual amino acid must be
arefully examined for each toxin, and a single amino acid residue
ight not be as critical for binding on one isoform as for other.
Very interestingly, our present data show that all the three tox-
ns tested do not have a high preference for binding on Nav1.2 (the
referential target of ATX-II, one of the most potent sea anemone
oxins). However, the supposed binding site (site 3) [8] of these
ype 1 sea anemone toxins in Nav1.1 is identical [23,30].  So, if only
his region in sodium channels is interacting with sea anemone
oxins, it is expected that any peptide which bind in Nav1.1 should
ave similar proﬁles of activity and afﬁnity in Nav1.2. However, our
resent data show a distinct evidence (see Figs. 1–3 and Table 2). As
bserved, both CGTX-II and -AITX-Bcg1a induce different effects
n Nav1.1 and 1.2.residues. Panel B depicts the charged molecular surfaces of each toxin, in the same
, respectively. (For interpretation of the references to color in this text, the reader
On Nav1.1 and 1.6, the peptides indeed shifted the Boltzmann
inactivation curves to more depolarized potentials and maintain a
pedestal (see Fig. 2), by the induction of a persistent current (steady-
state current – Ass), in contrary to that observed for the other clones
investigated and also reports by other authors [27,28]. This char-
acterizes a population of bound channels that do not inactivate.
In Nav1.2, the observed effects are distinct: CGTX-II causes some
slight shift in the Boltzmann curves for either activation and deac-
tivation toward more negative potentials, while -AITX-Bcg1a do
not alter these values. This effect may  be due to the occurrence
of a persistent current (Ass), which in turn strongly modify the so
called “window current” that is known to be able to alter the neu-
ronal resting potential and shift activation to more hyperpolarized
potential. In addition, the increase in the persistent currents by
both peptides is negligible, in comparison to Nav1.1. This clearly
suggests that the binding site of type 1 toxins is not restricted only
to the supposed site 3, between segments S3 and S4 of domain
IV, in agreement with previous results [23]. Also, a similar dis-
crete shift of activation toward more hyperpolarized potentials was
only observed in the toxin ApC when tested in rat DRG neurons
[27], suggesting that these sea anemone type 1 toxins might act
in some way as a -scorpion fashion, facilitating depolarization of
affected cells. Thus, further site-directed mutagenesis studies in
other regions of Navs should be performed in order to determine
the other contact regions between channel and sea anemone toxins,
as obviously other topological areas of such channels are involved
in these interactions. Moreover, these biophysical parameters also
reinforce the suggestion of dissimilar contact surfaces of each toxin
among different sodium channel isoforms.
In terms of the charge distribution of the peptides and the role of
positively charged amino acids, similar controversial results were
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ound. As for ATX-II, a Lys at position 35 was described to be crucial
or activity on rat Nav1.2 [25], while for the same molecule that
mino acid was not demonstrated either to alter its binding prop-
rties on neuronal cockroach membranes or decrease activity of
uman Nav1.5 expressed in Xenopus laevis oocytes [22]. In ApB case,
 Lys in the same position was demonstrated to be determinant
or its potency and activity, either in K37A or K37D substitutions
5]. Especially in the ApB-K37D mutant, its potency was  drastically
ffected. Observing Table 1, we can see that -AITX-Bcg1a has a
egative amino acid residue in its 38th position, where the above
entioned positively charged residues were supposed to be critical.
On the other hand, CgNa is a toxin isolated from Condylac-
is gigantea species and presents a dense negative charge around
esidues 35–37 (see Table 1). In spite of the presence of such a neg-
tive charge its potency is in a similar range such as BgII when tested
n dorsal root ganglia (DRG) neurons [28,29,32].  Also, the determi-
ation of CgNa three-dimensional structure by NMR  exhibits a large
egative patch exposed, and a minor distribution of hydrophobic
esidues that are important for activity in ApB and ATX-II [29]. As
ointed by the authors, this may  explain that at least for CgNa
he presence of positively charged amino acids and a hydrophobic
atch may  not be of utmost importance for its binding on sodium
hannels, but might contribute to a smaller potency compared to
TX-II and ApB, for instance.
Observing the modeled structures shown in Fig. 5, we  clearly
ee that for -AITX-Bcg1a peptide an overall charge distribution
imilar to CgNa may  occur. In its primary sequence, we  observe a
egatively charged amino acid (D37) that is positioned in a corre-
pondent region of D36 and E37 in CgNa, and their contact surface
n sodium channels may  also be similar. Comparing among the
harged molecular surfaces of the three toxins, -AITX-Bcg1a has a
ore intense negatively charged surface when compared to CGTX-
I. As for -AITX-Bcg1b, the occurrence of an Asp at position 16 may
isrupt this possible surface of contact, by increasing the extent
f the negative patch and make -AITX-Bcg1b much less prone
o affect VGSC, as shown in Fig. 1. This is especially interesting as
e consider the only N16D substitution observed between -AITX-
cg1a and -AITX-Bcg1b, but the molecular surface of the latter
hows that the occurrence of Asp16 drastically increases the nega-
ively charged surface among all three peptides. Consequently, we
ay  suggest that the large negative surface observed in -AITX-
cg1b may  be responsible for its mild effects among the assayed
avs.
. Conclusions
In summary, our results contribute to a better understanding
f the selectivity of some sea anemone toxins toward channels
av1.1–1.7. The presented data demonstrate that the binding sites
f these toxins is not restricted to the supposed site 3, between
egments S3 and S4 of domain IV.
Also, we show that previously assumed critical amino acid
ositions in this group of peptides may  vary and should be
arefully considered. By doing this we may  avoid misleading
nterpretations by common generalizations that may  arise from
ite-directed mutagenesis studies. Moreover, subtle variations in
rimary sequences of toxins may  lead to drastic changes in surface
harges, such as in the case of -AITX-Bcg1a and -AITX-Bcg1b,
hich may  contribute to a better understanding of their contact
urfaces on the targeted channels.cknowledgments
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